Topics

Eisai, Biogen scrap late-stage development of BACE inhibitor elenbecestat in early Alzheimer's disease https://www.firstwordpharma.com/node/1666114  $BIIB

09:16 EDT 13 Sep 2019 | FirstWord Pharma

Eisai, Biogen scrap late-stage development of BACE inhibitor elenbecestat in early Alzheimer's disease https://www.firstwordpharma.com/node/1666114 

Original Article: Eisai, Biogen scrap late-stage development of BACE inhibitor elenbecestat in early Alzheimer's disease https://www.firstwordpharma.com/node/1666114  $BIIB

NEXT ARTICLE

More From BioPortfolio on "Eisai, Biogen scrap late-stage development of BACE inhibitor elenbecestat in early Alzheimer's disease https://www.firstwordpharma.com/node/1666114  $BIIB"

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...